The SECURE Study Long-Term Safety of Ranibizumab 0.5 mg in Neovascular Age-related Macular Degeneration

Silva R., Axer-Siegel R., Eldem B., Guymer R., Kirchhof B., Papp A., ...More

OPHTHALMOLOGY, vol.120, no.1, pp.130-139, 2013 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 120 Issue: 1
  • Publication Date: 2013
  • Doi Number: 10.1016/j.ophtha.2012.07.026
  • Journal Name: OPHTHALMOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.130-139
  • Hacettepe University Affiliated: Yes


Objective: To evaluate long-term safety of intravitreal ranibizumab 0.5-mg injections in neovascular age-related macular degeneration (nAMD).